Evidence map›Paper›PMID 21671584›Full record

ArticleBiochemistry2011

Friedreich's ataxia variants I154F and W155R diminish frataxin-based activation of the iron-sulfur cluster assembly complex.

Chi-Lin Tsai, Jennifer Bridwell-Rabb, David P Barondeau

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Phenotypic variation of FXN compound heterozygotes in a Friedreich ataxia cohort.Annals of clinical and translational neurology · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Mechanism of activation of the human cysteine desulfurase complex by frataxin.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  11. Article
  12. Article
  13. Identification of a novel missense mutation in Friedreich's ataxia -FXNAnnals of clinical and translational neurology · 2019
    Article
  14. Impact ofInternational journal of molecular sciences · 2018
    Review
  15. Article
  16. Article
  17. Selected missense mutations impair frataxin processing in Friedreich ataxia.Annals of clinical and translational neurology · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chi-Lin Tsaibarondeau@tamu.edu
Jennifer Bridwell-Rabb
David P Barondeau

Funding

Structure and Mechanism of the Human FE-S Cluster Assembly ComplexR01GM096100 · NIGMS · TEXAS A&M UNIVERSITY · PI BARONDEAU, DAVID P · 2011 to 2024
$3.5M
NIGMS NIH HHS R01 GM096100
6 · The paper itself

Abstract

Friedreich's ataxia (FRDA) is a progressive neurodegenerative disease that has been linked to defects in the protein frataxin (Fxn). Most FRDA patients have a GAA expansion in the first intron of their Fxn gene that decreases protein expression. Some FRDA patients have a GAA expansion on one allele and a missense mutation on the other allele. Few functional details are known for the ∼15 different missense mutations identified in FRDA patients. Here in vitro evidence is presented that indicates the FRDA I154F and W155R variants bind more weakly to the complex of Nfs1, Isd11, and Isu2 and thereby are defective in forming the four-component SDUF complex that constitutes the core of the Fe-S cluster assembly machine. The binding affinities follow the trend Fxn ∼ I154F > W155F > W155A ∼ W155R. The Fxn variants also have diminished ability to function as part of the SDUF complex to stimulate the cysteine desulfurase reaction and facilitate Fe-S cluster assembly. Four crystal structures, including the first for a FRDA variant, reveal specific rearrangements associated with the loss of function and lead to a model for Fxn-based activation of the Fe-S cluster assembly complex. Importantly, the weaker binding and lower activity for FRDA variants correlate with the severity of disease progression. Together, these results suggest that Fxn facilitates sulfur transfer from Nfs1 to Isu2 and that these in vitro assays are sensitive and appropriate for deciphering functional defects and mechanistic details for human Fe-S cluster biosynthesis.

Indexed as

Allosteric RegulationCarbon-Sulfur LyasesCrystallography, X-RayEnzyme ActivationFrataxinFriedreich AtaxiaHumansIron-Binding ProteinsIron-Sulfur ProteinsKineticsModels, MolecularMultiprotein ComplexesMutant ProteinsProtein BindingSulfidesCarbon-Sulfur Lyasescysteine desulfuraseFrataxinIron-Binding ProteinsIron-Sulfur ProteinsMultiprotein ComplexesMutant ProteinsSulfides

Identifiers

PMID21671584
PMCPMC3319458
OpenAlexW1990773197

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.